2146. Antimicrobial Activity of Aztreonam-avibactam, Ceftazidime-avibactam, and Meropenem-vaborbactam against Enterobacterales causing Bloodstream Infection in US Medical Centers (2020–2022)

BACKGROUND: As the frequency of Enterobacterales (ENT) producing metallo-β-lactamase (MBL) and/or OXA-48 is increasing in some US medical centers, effective antimicrobials to treat the infections caused by these organisms are urgently needed. Aztreonam-avibactam (ATM-AVI) is under clinical developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Sader, Helio S, Carvalhaes, Cecilia G, Kimbrough, John H, Mendes, Rodrigo E, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677969/
http://dx.doi.org/10.1093/ofid/ofad500.1769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677969/
http://dx.doi.org/10.1093/ofid/ofad500.1769

Ejemplares similares